Vaccines Archives

covid-19 vaccine emergency use authorization

News and Trends 29 Aug 2022

AIVITA Biomedical announces publication of trial results of its COVID-19 vaccine

Safety and efficacy results from phase 1 and 2 clinical trials looking at a Covid-19 vaccine made at point-of-care by third party personnel have been published. AIVITA Biomedical Inc., a biotech specializing in cell applications, made the announcement today (August 29). The results were published in the article in the journal Human Vaccines & Immunotherapeutics. […]

August 29, 2022 - 3 minutesmins - By Liza Laws

Covid vaccine lawsuit: Moderna vs Pfizer

News and Trends 26 Aug 2022

Moderna to sue Pfizer and German partner, BioNTech, for allegedly “copying technology”

Moderna is today (August 26) filing patent infringement lawsuits against Pfizer and its partner BioNTech in both the U.S and Germany. The mRNA-focused biotech claims the companies’ Covid-19 vaccine Comirnaty infringes patents it led between 2010 and 2016 covering Moderna’s foundational mRNA technology which the company says was critical to the development of its own […]

August 26, 2022 - 4 minutesmins - By Liza Laws

News and Trends 26 Aug 2022

Swedish researchers developing new treatment for chronic hepatitis B and D infections

A new immunological treatment against hepatitis B and D viruses, both of which can cause liver cancer, shows promising results in animal models. Results from the treatment, which is being developed by researchers at Karolinska Institutet in Sweden, have been published in the journal Gut. Chronic infections of the hepatitis B virus (HBV) and hepatitis […]

August 26, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 25 Aug 2022

KU Leuven spin-off AstriVax raises €30M for vaccine platform – first stop, yellow fever

A Belgian university spinoff has generated the biggest seed capital financing in the institution’s history. Closing with €30 million ($30 million), AstriVax will draw on technology developed at the KU Leuven Rega Institute to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various […]

August 25, 2022 - 3 minutesmins - By Jim Cornall

More News! 24 Aug 2022

COVID-19 vaccine less sensitive to mutations being developed in Sweden

A new generation of coronavirus vaccine is being developed by Swedish researchers from the Karolinska Institutet. The vaccine is being specifically designed to be less sensitive to mutations and better equipped for any future strains. Promising results The vaccine showed promising results in mice in a newly published study in EMBO Molecular Medicine, and the researchers […]

August 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 23 Aug 2022

Institute for Bioscience and Biotechnology Research awarded $6.9M to work on hepatitis C vaccine

The National Institute of Allergy and Infectious Disease (NIAID) has awarded a $6.9 million grant to researchers at the Institute for Bioscience and Biotechnology Research (IBBR) to design a vaccine to combat the virus that causes hepatitis C. Hepatitis C is an illness that affects an estimated 71 million people worldwide. Hepatitis C Virus (HCV) […]

August 23, 2022 - 2 minutesmins - By Jim Cornall

In Depth 28 Jul 2022

How can vaccines keep up with evolving Covid-19 variants?

Vaccines for COVID-19 have saved lives all over the world, but their protection is threatened by the rise of variants of concern. Companies are developing ways to combat the evolving virus, such as booster shots and universal coronavirus vaccines. During 2021, a plethora of COVID-19 vaccines was rolled out around the world. Since then, mass […]

July 28, 2022 - 7 minutesmins - By Jonathan Smith

Daniel Baptista-Hon Faculty of Medicine M.U.S.T. Macao

News and Trends 25 Jul 2022

Macao university research finds mRNA vaccine booster offers more protection against Omicron variants

A study in Macao has found people taking the BioNTech mRNA vaccine as the third booster dose produce more neutralizing antibodies against Omicron variants. The study, led by Daniel Baptista-Hon, assistant professor at the Faculty of Medicine at the Macau University of Science and Technology (M.U.S.T.), and Ligong Lu, director of Zhuhai People’s Hospital, was […]

July 25, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 21 Jul 2022

Vicebio exits stealth to work on next generation RSV vaccine

Vicebio Ltd, a biopharmaceutical company founded by Medicxi in 2019, has launched to accelerate the development of novel vaccines against life-threatening respiratory viral infections using its molecular clamp technology platform. The technology has been developed by Paul Young, Daniel Watterson, Keith Chappell and their groups at The University of Queensland (UQ), Brisbane, Australia. It was […]

July 21, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 20 Jul 2022

IVI and Moderna sign MOU for vaccine R&D

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Moderna, a biotech company working on messenger RNA (mRNA) therapeutics and vaccines, have signed a Memorandum of Understanding (MOU) to partner on collaborative vaccine research and development. “IVI welcomes this […]

July 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jul 2022

SINOVAC starts influenza vaccine trial in Chile

Sinovac Biotech Ltd., a provider of biopharmaceutical products in China, has initiated a phase III clinical trial for SINOVAC’s inactivated quadrivalent influenza vaccine in Chile through a collaboration with the Pontificia Universidad Católica de Chile. SINOVAC said the results aim to provide scientific evidence to support its influenza vaccine immunogenicity and protection capacity. This clinical […]

July 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jul 2022

SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine

South Korean company SK Bioscience has extended its partnership with Novavax, Inc., a U.S. biotechnology company specializing in next-generation vaccines, for the manufacturing and supply of Novavax COVID-19 vaccine targeting Omicron variants in prefilled syringes. SK Bioscience and Novavax signed an agreement for the technology transfer of Novavax proprietary COVID-19 variant antigen materials and manufacturing […]

July 19, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Vaccines

AIVITA Biomedical announces publication of trial results of its COVID-19 vaccine

Moderna to sue Pfizer and German partner, BioNTech, for allegedly “copying technology”

Swedish researchers developing new treatment for chronic hepatitis B and D infections

KU Leuven spin-off AstriVax raises €30M for vaccine platform – first stop, yellow fever

COVID-19 vaccine less sensitive to mutations being developed in Sweden

Institute for Bioscience and Biotechnology Research awarded $6.9M to work on hepatitis C vaccine

How can vaccines keep up with evolving Covid-19 variants?

Macao university research finds mRNA vaccine booster offers more protection against Omicron variants

Vicebio exits stealth to work on next generation RSV vaccine

IVI and Moderna sign MOU for vaccine R&D

SINOVAC starts influenza vaccine trial in Chile

SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!